Thanks @LeftYahoo and @otherperspective - great posts as usual.
One question that has been nagging at me.
"This is a SEISMIC shift to my mind and underlines perhaps a deeper significance of the CHF study that few seen to have perceived: rex-L may ultimately have a greater role as a prophylactic than as a traditional therapeutic." and that can be extended to Rem-L for C19 ARDS too as our sweet spot is no longer the "sickest of the sick" patients...
A long way to go, but will the industry/ insurers (i.e. Pharmacoeconomic) support such a costly preventative treatment?
Costs associated with preventative measures have a different value to the actual treatment itself, at least to the patients.
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
MSB
mesoblast limited
Add to My Watchlist
1.55%
!
$1.59

Cell Therapy News/Articles, page-8233
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.59 |
Change
-0.025(1.55%) |
Mkt cap ! $2.031B |
Open | High | Low | Value | Volume |
$1.61 | $1.62 | $1.57 | $6.345M | 3.987M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 44493 | $1.59 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.59 | 4159 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 44493 | 1.585 |
11 | 152673 | 1.580 |
11 | 113158 | 1.575 |
21 | 148384 | 1.570 |
3 | 78851 | 1.565 |
Price($) | Vol. | No. |
---|---|---|
1.590 | 4159 | 1 |
1.595 | 17500 | 2 |
1.600 | 48600 | 4 |
1.605 | 38500 | 3 |
1.610 | 5000 | 1 |
Last trade - 16.10pm 08/07/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |